Tag: medicine_access

Pharmac Expands Rosuvastatin Access for All New Zealanders

30 Jun 2026 1:30 p.m. · Source: New Zealand Government

Pharmac will widen access to Rosuvastatin from October 1, 2026, removing all eligibility criteria, including ethnicity. This move aims to improve health outcomes and reduce hospital admissions for high cholesterol patients.

Health Politics and Government Medical Science General Politics Economy Social Issues Rosuvastatin Pharmac cholesterol heart disease David Seymour medicine access New Zealand Government